SynthesisTherapeutic advances in cardiovascular disease

Empagliflozin and other SGLT2 inhibitors in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis.

Abdulrahman Khaldoon Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.